Hypocrites! Social Media Reactions and Stakeholder Backlash to Conflicting CSR Information [PDF]
Lisa D. Lewin, Danielle E. Warren
openalex +1 more source
Association Between Mass Media Use and Maternal Healthcare Service Utilisation in Malawi
, 2021 Yanjie Wang +5 more
openalex +2 more sources
Message To Faculty, Students And Staff At The University Of New Hampshire April 17, 2006 [PDF]
, 2007 UNH Media Relations
core +2 more sources
Strength through diversity: how cancers thrive when clones cooperate
Molecular Oncology, EarlyView.Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
Development and validation of social compensation design scale for urban older users in the context of smart-home social media. [PDF]
Digit HealthMa K +5 more
europepmc +1 more source
A self-similar analytical solution of spontaneous and forced imbibition in porous media [PDF]
, 2018 Xiukun Wang, James J. Sheng
openalex +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
Molecular Oncology, EarlyView.This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Key Sources of Information and Support for Adults With Coeliac Disease: Coeliac Associations, Dietitians, Social Media and Cookbooks. [PDF]
J Hum Nutr DietJeanes Y +6 more
europepmc +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
Molecular Oncology, EarlyView.WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source